Does the media refer more to CAH or COR?

In the previous week, Cardinal Health had 3 more articles in the media than Cencora. MarketBeat recorded 23 mentions for Cardinal Health and 20 mentions for Cencora. Cencora's average media sentiment score of 1.36 beat Cardinal Health's score of 1.28 indicating that Cencora is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardinal Health 18 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cencora 16 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ELV or COR?

In the previous week, Elevance Health had 23 more articles in the media than Cencora. MarketBeat recorded 43 mentions for Elevance Health and 20 mentions for Cencora. Cencora's average media sentiment score of 1.36 beat Elevance Health's score of 1.12 indicating that Cencora is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 27 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cencora 16 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, COR or MCK?

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cencora $321.33B 0.19 $1.55B $13.04 23.97 McKesson $403.43B 0.25 $4.76B $38.47 22.54

Is COR or MCK more profitable?

McKesson has a net margin of 1.18% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets Cencora 0.78% 135.20% 4.20% McKesson 1.18% -345.35% 5.85%

Does the media refer more to COR or MCK?

In the previous week, McKesson had 29 more articles in the media than Cencora. MarketBeat recorded 49 mentions for McKesson and 20 mentions for Cencora. Cencora's average media sentiment score of 1.36 beat McKesson's score of 1.23 indicating that Cencora is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 16 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 37 Very Positive mention(s) 7 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, HSIC or COR?

Cencora has higher revenue and earnings than Henry Schein. Cencora is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Henry Schein $13.18B 0.74 $398M $3.31 25.73 Cencora $321.33B 0.19 $1.55B $13.04 23.97

Is HSIC or COR more profitable?

Henry Schein has a net margin of 2.95% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat Henry Schein's return on equity. Company Net Margins Return on Equity Return on Assets Henry Schein 2.95% 15.44% 5.53% Cencora 0.78% 135.20% 4.20%

Does the media prefer HSIC or COR?

In the previous week, Cencora had 5 more articles in the media than Henry Schein. MarketBeat recorded 20 mentions for Cencora and 15 mentions for Henry Schein. Cencora's average media sentiment score of 1.36 beat Henry Schein's score of 0.96 indicating that Cencora is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 5 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cencora 16 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, COR or CVS?

CVS Health has higher revenue and earnings than Cencora. Cencora is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cencora $321.33B 0.19 $1.55B $13.04 23.97 CVS Health $402.07B 0.33 $1.77B $2.27 46.35

Is COR or CVS more profitable?

Cencora has a net margin of 0.78% compared to CVS Health's net margin of 0.72%. Cencora's return on equity of 135.20% beat CVS Health's return on equity. Company Net Margins Return on Equity Return on Assets Cencora 0.78% 135.20% 4.20% CVS Health 0.72% 11.88% 3.54%

Does the media favor COR or CVS?

In the previous week, CVS Health had 36 more articles in the media than Cencora. MarketBeat recorded 56 mentions for CVS Health and 20 mentions for Cencora. Cencora's average media sentiment score of 1.36 beat CVS Health's score of 0.77 indicating that Cencora is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 16 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVS Health 31 Very Positive mention(s) 10 Positive mention(s) 11 Neutral mention(s) 2 Negative mention(s) 2 Very Negative mention(s) Positive

Cencora (COR) Competitors

$312.58 -6.03 (-1.89%)

Closing price 07/30/2026 03:59 PM Eastern

Extended Trading

$307.63 -4.96 (-1.59%)

As of 06:28 AM Eastern

Compare

COR vs. CAH, ELV, MCK, HSIC, and CVS

Should you buy Cencora stock or one of its competitors? MarketBeat compares Cencora with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cencora include Cardinal Health (CAH), Elevance Health (ELV), McKesson (MCK), Henry Schein (HSIC), and CVS Health (CVS). These companies are all part of the "medical" sector.

How does Cencora compare to Cardinal Health?

Cardinal Health (NYSE:CAH) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

Cardinal Health pays an annual dividend of $2.06 per share and has a dividend yield of 0.9%. Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.8%. Cardinal Health pays out 31.5% of its earnings in the form of a dividend. Cencora pays out 18.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cardinal Health has raised its dividend for 29 consecutive years and Cencora has raised its dividend for 15 consecutive years. Cardinal Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cencora has a net margin of 0.78% compared to Cardinal Health's net margin of 0.62%. Cencora's return on equity of 135.20% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardinal Health	0.62%	-92.61%	4.46%
Cencora	0.78%	135.20%	4.20%

Cardinal Health has higher earnings, but lower revenue than Cencora. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardinal Health	$222.58B	0.24	$1.56B	$6.54	34.76
Cencora	$321.33B	0.19	$1.55B	$13.04	23.97

Cardinal Health has a beta of 0.49, meaning that its stock price is 51% less volatile than the broader market. Comparatively, Cencora has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market.

Cardinal Health currently has a consensus target price of $251.73, suggesting a potential upside of 10.75%. Cencora has a consensus target price of $367.75, suggesting a potential upside of 17.65%. Given Cencora's higher probable upside, analysts clearly believe Cencora is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.83
Cencora	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

In the previous week, Cardinal Health had 3 more articles in the media than Cencora. MarketBeat recorded 23 mentions for Cardinal Health and 20 mentions for Cencora. Cencora's average media sentiment score of 1.36 beat Cardinal Health's score of 1.28 indicating that Cencora is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardinal Health	18 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cencora	16 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by insiders. Comparatively, 0.4% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Cencora beats Cardinal Health on 10 of the 19 factors compared between the two stocks.

How does Cencora compare to Elevance Health?

Elevance Health (NYSE:ELV) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Elevance Health presently has a consensus price target of $440.90, suggesting a potential upside of 17.35%. Cencora has a consensus price target of $367.75, suggesting a potential upside of 17.65%. Given Cencora's stronger consensus rating and higher possible upside, analysts plainly believe Cencora is more favorable than Elevance Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65
Cencora	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Elevance Health has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market. Comparatively, Cencora has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market.

Elevance Health has a net margin of 2.47% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat Elevance Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.47%	14.64%	5.22%
Cencora	0.78%	135.20%	4.20%

Elevance Health has higher earnings, but lower revenue than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.41	$5.66B	$22.50	16.70
Cencora	$321.33B	0.19	$1.55B	$13.04	23.97

In the previous week, Elevance Health had 23 more articles in the media than Cencora. MarketBeat recorded 43 mentions for Elevance Health and 20 mentions for Cencora. Cencora's average media sentiment score of 1.36 beat Elevance Health's score of 1.12 indicating that Cencora is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	27 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cencora	16 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 0.4% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.8%. Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.8%. Elevance Health pays out 30.6% of its earnings in the form of a dividend. Cencora pays out 18.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years and Cencora has increased its dividend for 15 consecutive years.

Summary

Cencora beats Elevance Health on 10 of the 19 factors compared between the two stocks.

How does Cencora compare to McKesson?

Cencora (NYSE:COR) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.

In the previous week, McKesson had 29 more articles in the media than Cencora. MarketBeat recorded 49 mentions for McKesson and 20 mentions for Cencora. Cencora's average media sentiment score of 1.36 beat McKesson's score of 1.23 indicating that Cencora is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	16 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	37 Very Positive mention(s)	7 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Cencora presently has a consensus target price of $367.75, indicating a potential upside of 17.65%. McKesson has a consensus target price of $962.67, indicating a potential upside of 11.03%. Given Cencora's higher possible upside, analysts clearly believe Cencora is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.19	$1.55B	$13.04	23.97
McKesson	$403.43B	0.25	$4.76B	$38.47	22.54

Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.8%. McKesson pays an annual dividend of $3.76 per share and has a dividend yield of 0.4%. Cencora pays out 18.4% of its earnings in the form of a dividend. McKesson pays out 9.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has raised its dividend for 15 consecutive years and McKesson has raised its dividend for 17 consecutive years.

97.5% of Cencora shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 0.4% of Cencora shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

McKesson has a net margin of 1.18% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.78%	135.20%	4.20%
McKesson	1.18%	-345.35%	5.85%

Cencora has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market. Comparatively, McKesson has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

Summary

McKesson beats Cencora on 11 of the 19 factors compared between the two stocks.

How does Cencora compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Cencora (NYSE:COR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

Henry Schein currently has a consensus price target of $89.36, suggesting a potential upside of 4.92%. Cencora has a consensus price target of $367.75, suggesting a potential upside of 17.65%. Given Cencora's stronger consensus rating and higher probable upside, analysts plainly believe Cencora is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47
Cencora	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

In the previous week, Cencora had 5 more articles in the media than Henry Schein. MarketBeat recorded 20 mentions for Cencora and 15 mentions for Henry Schein. Cencora's average media sentiment score of 1.36 beat Henry Schein's score of 0.96 indicating that Cencora is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	5 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cencora	16 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 0.4% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Henry Schein has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market. Comparatively, Cencora has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

Henry Schein has a net margin of 2.95% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
Cencora	0.78%	135.20%	4.20%

Cencora has higher revenue and earnings than Henry Schein. Cencora is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.74	$398M	$3.31	25.73
Cencora	$321.33B	0.19	$1.55B	$13.04	23.97

Summary

Cencora beats Henry Schein on 10 of the 16 factors compared between the two stocks.

How does Cencora compare to CVS Health?

Cencora (NYSE:COR) and CVS Health (NYSE:CVS) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

Cencora currently has a consensus price target of $367.75, suggesting a potential upside of 17.65%. CVS Health has a consensus price target of $105.67, suggesting a potential upside of 0.43%. Given Cencora's higher probable upside, equities research analysts plainly believe Cencora is more favorable than CVS Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
CVS Health	0 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	0 Strong Buy rating(s)	2.88

Cencora has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

97.5% of Cencora shares are owned by institutional investors. Comparatively, 80.7% of CVS Health shares are owned by institutional investors. 0.4% of Cencora shares are owned by insiders. Comparatively, 0.9% of CVS Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Cencora has a net margin of 0.78% compared to CVS Health's net margin of 0.72%. Cencora's return on equity of 135.20% beat CVS Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.78%	135.20%	4.20%
CVS Health	0.72%	11.88%	3.54%

In the previous week, CVS Health had 36 more articles in the media than Cencora. MarketBeat recorded 56 mentions for CVS Health and 20 mentions for Cencora. Cencora's average media sentiment score of 1.36 beat CVS Health's score of 0.77 indicating that Cencora is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	16 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CVS Health	31 Very Positive mention(s)	10 Positive mention(s)	11 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Positive

CVS Health has higher revenue and earnings than Cencora. Cencora is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.19	$1.55B	$13.04	23.97
CVS Health	$402.07B	0.33	$1.77B	$2.27	46.35

Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.8%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.5%. Cencora pays out 18.4% of its earnings in the form of a dividend. CVS Health pays out 117.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cencora has raised its dividend for 15 consecutive years and CVS Health has raised its dividend for 4 consecutive years.

Summary

CVS Health beats Cencora on 10 of the 19 factors compared between the two stocks.

Get Cencora News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COR vs. The Competition

Export

Metric	Cencora	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$61.99B	$9.64B	$7.04B	$23.53B
Dividend Yield	0.75%	1.57%	2.65%	4.19%
P/E Ratio	23.97	26.03	27.69	30.73
Price / Sales	0.19	18.78	488.19	81.94
Price / Cash	14.74	135.30	51.74	31.18
Price / Book	34.69	6.13	10.04	4.66
Net Income	$1.55B	$179.69M	$3.60B	$1.07B
7 Day Performance	0.94%	-0.43%	0.66%	0.55%
1 Month Performance	10.36%	-1.91%	-3.29%	1.58%
1 Year Performance	9.27%	16.43%	24.47%	17.66%

Cencora Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COR Cencora	4.8769 of 5 stars	$312.58 -1.9%	$367.75 +17.6%	+7.1%	$61.99B	$321.33B	23.97	51,000	Positive News Upcoming Earnings Gap Down
CAH Cardinal Health	4.5465 of 5 stars	$229.49 +0.6%	$251.73 +9.7%	+43.9%	$53.78B	$222.58B	35.11	57,700	Positive News
ELV Elevance Health	4.8979 of 5 stars	$377.95 +0.1%	$440.90 +16.7%	+27.8%	$81.95B	$201.11B	16.79	97,100	Trending News Analyst Revision
MCK McKesson	4.8254 of 5 stars	$854.72 +1.6%	$962.67 +12.6%	+21.3%	$100.17B	$403.43B	22.24	43,000	Trending News Upcoming Earnings Gap Down
HSIC Henry Schein	3.5685 of 5 stars	$84.86 -0.7%	$88.62 +4.4%	+22.4%	$9.68B	$13.38B	25.67	25,000	Upcoming Earnings Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:COR) was last updated on 7/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cencora (COR) Competitors

COR vs. CAH, ELV, MCK, HSIC, and CVS

How does Cencora compare to Cardinal Health?

Summary

How does Cencora compare to Elevance Health?

Summary

How does Cencora compare to McKesson?

Summary

How does Cencora compare to Henry Schein?

Summary

How does Cencora compare to CVS Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COR vs. The Competition

Cencora Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cencora (COR) Competitors

COR vs. CAH, ELV, MCK, HSIC, and CVS

How does Cencora compare to Cardinal Health?

Is CAH or COR a better dividend stock?

Is CAH or COR more profitable?

Which has better earnings and valuation, CAH or COR?

Which has more volatility & risk, CAH or COR?

Do analysts prefer CAH or COR?

Does the media refer more to CAH or COR?

Do institutionals & insiders hold more shares of CAH or COR?

Summary

How does Cencora compare to Elevance Health?

Do analysts rate ELV or COR?

Which has more risk & volatility, ELV or COR?

Is ELV or COR more profitable?

Which has higher earnings and valuation, ELV or COR?

Does the media refer more to ELV or COR?

Do insiders & institutionals believe in ELV or COR?

Is ELV or COR a better dividend stock?

Summary

How does Cencora compare to McKesson?

Does the media refer more to COR or MCK?

Do analysts recommend COR or MCK?

Which has higher valuation and earnings, COR or MCK?

Is COR or MCK a better dividend stock?

Do institutionals & insiders hold more shares of COR or MCK?

Is COR or MCK more profitable?

Which has more volatility & risk, COR or MCK?

Summary

How does Cencora compare to Henry Schein?

Do analysts prefer HSIC or COR?

Does the media prefer HSIC or COR?

Do institutionals & insiders hold more shares of HSIC or COR?

Which has more risk & volatility, HSIC or COR?

Is HSIC or COR more profitable?

Which has better earnings and valuation, HSIC or COR?

Summary

How does Cencora compare to CVS Health?

Do analysts recommend COR or CVS?

Which has more volatility & risk, COR or CVS?

Do institutionals & insiders have more ownership in COR or CVS?

Is COR or CVS more profitable?

Does the media favor COR or CVS?

Which has better earnings & valuation, COR or CVS?

Is COR or CVS a better dividend stock?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COR vs. The Competition

Cencora Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools